Lexeo Therapeutics (LXEO) Return on Sales (2023)
Historic Return on Sales for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to 283.74%.
- Lexeo Therapeutics' Return on Sales changed N/A to 283.74% in Q4 2023 from the same period last year, while for Dec 2023 it was 323.87%, marking a year-over-year change of. This contributed to the annual value of 717.76% for FY2024, which is 3938900.0% up from last year.
- Per Lexeo Therapeutics' latest filing, its Return on Sales stood at 283.74% for Q4 2023.
- Lexeo Therapeutics' 5-year Return on Sales high stood at 386.69% for Q3 2023, and its period low was 32.12% during Q3 2022.